Tags

Type your tag names separated by a space and hit enter

A survey of current evaluation and treatment of gout.
J Rheumatol 2006; 33(10):2050-2JR

Abstract

OBJECTIVE

To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists.

METHODS

Questionnaires were faxed to 2500 US rheumatologists.

RESULTS

Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80% of the time for new suspected gout; 64% use combination therapy for acute gout; nonsteroidal antiinflammatory drugs alone are used in only 27%. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4%) but most frequently to patients after 2 (59%) or 3 (34%) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl.

CONCLUSION

Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance.

Authors+Show Affiliations

Department of Medicine, The School of Public Health, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey 08903-0019, USA. schlesna@umdnj.eduNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

17014020

Citation

Schlesinger, Naomi, et al. "A Survey of Current Evaluation and Treatment of Gout." The Journal of Rheumatology, vol. 33, no. 10, 2006, pp. 2050-2.
Schlesinger N, Moore DF, Sun JD, et al. A survey of current evaluation and treatment of gout. J Rheumatol. 2006;33(10):2050-2.
Schlesinger, N., Moore, D. F., Sun, J. D., & Schumacher, H. R. (2006). A survey of current evaluation and treatment of gout. The Journal of Rheumatology, 33(10), pp. 2050-2.
Schlesinger N, et al. A Survey of Current Evaluation and Treatment of Gout. J Rheumatol. 2006;33(10):2050-2. PubMed PMID: 17014020.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A survey of current evaluation and treatment of gout. AU - Schlesinger,Naomi, AU - Moore,Dirk F, AU - Sun,Jennifer D, AU - Schumacher,H Ralph,Jr PY - 2006/10/3/pubmed PY - 2007/2/21/medline PY - 2006/10/3/entrez SP - 2050 EP - 2 JF - The Journal of rheumatology JO - J. Rheumatol. VL - 33 IS - 10 N2 - OBJECTIVE: To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists. METHODS: Questionnaires were faxed to 2500 US rheumatologists. RESULTS: Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80% of the time for new suspected gout; 64% use combination therapy for acute gout; nonsteroidal antiinflammatory drugs alone are used in only 27%. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4%) but most frequently to patients after 2 (59%) or 3 (34%) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl. CONCLUSION: Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance. SN - 0315-162X UR - https://www.unboundmedicine.com/medline/citation/17014020/A_survey_of_current_evaluation_and_treatment_of_gout_ L2 - http://www.jrheum.org/cgi/pmidlookup?view=long&amp;pmid=17014020 DB - PRIME DP - Unbound Medicine ER -